MedPath

Efficacy of intravenous immunoglobulin replacement therapy for hypogammaglobulinemia in severe infections

Not Applicable
Conditions
severe infectious diseases
Registration Number
JPRN-UMIN000032802
Lead Sponsor
Sapporo Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

1) A case of death or survival within 24 hours after admitting to the ICU 2) Child under 15 years old

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
prognosis (ICU mortality rate, 28 days mortality rate, 90-days mortality rate, hospital mortality rate)
Secondary Outcome Measures
NameTimeMethod
1) characteristics of the patients 2) the severity of organ failure: SOFA score JAAM-DIC score 3) Serum IgG value and IVIG dosage at admitting to the ICU 4) Evaluation of reactivity to the treatment: Changes in SOFA score, Days of vasopressors, Length of ICU days, Hospitalized Days, ventilator days
© Copyright 2025. All Rights Reserved by MedPath